Experimental models of systemic lupus erythematosus: Anti-dsDNA in murine lupus

Rheumatology

Volumn 44, Issue 9, 2005, Pages 1086-1089

  Blank, M ^a   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Autoimmunity; Clearance; Necrosis; Phagocytosis; SLE

Indexed keywords

ALPHA ACTININ; ANTINUCLEAR ANTIBODY; CROSS REACTING ANTIBODY; DNA; DNA ANTIBODY; DOUBLE STRANDED DNA; EPITOPE; FAS ANTIGEN; FAS LIGAND; HISTONE ANTIBODY; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; SURVIVIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENTARITY DETERMINING REGION; CPG ISLAND; CYTOKINE RELEASE; DNA METHYLATION; EDITORIAL; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOLECULAR MIMICRY; NONHUMAN; NUCLEOSOME; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; DISEASE MODELS, ANIMAL; DNA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED STRAINS;

EID: 24144451905     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh695     Document Type: Editorial

References (66)

1. Berden JH. Lupus nephritis. Kidney Int 1997;52:538-58.
2. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34:501-37.
3. Rekvig OP, Nossent JC. Anti-dsDNAantibodies, nucleosomes, and systemic lupus erythematosus: A time for new paradigms? Arthritis Rheum 2003;48:300-12.
4. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: A major immunogen for the pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-81.
5. Kaliyaperumal A, Michaels MA, Datta SK. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: Tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol 1999;162:5775-83.
6. Casiola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
7. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997;185:843-54.
8. Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998;41:1152-60.
9. Bijl M, Limburg PC, Kallenberg CGM. New insights into the pathogenesis of systemic lupus erythematosus (SLE): The role of apoptosis. Neth J Med 2001;59:66-75.
10. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
12. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune 1pr/ 1pr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993;90:4409-13.
13. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
14. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 2003; 170:3223-32.
15. Licht R, Dicker JW, Jacobs CW, Tax WJ, Berden JH. Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 2004;22:139-45.
16. Herrmann M, Voll RE, Zeller OM, Hagenhofer M, Penner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
17. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mono-nuclear cells in systemic lupus erythematosus. Lupus 1998;7:113-8.
18. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
19. Tao D, Shangwu L, Qun W et al. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2005;174:1281-90.
20. Scott RS, McMahon EJ, Pop SM et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001;411:207-11.
21. Cohen PL, Caricchio R, Abraham V et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002;196:135-40.
22. Mevorach D. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann N Y Acad Sci 2000;926:226-35.
23. Bickerstaff MCM, Botto M, Hutchinson W et al. Serum amyloid P component controls chromatin degradation and prevents anti-nuclear autoimmunity. Nat Med 1999;5:694-7.
24. Bijl M, Horst G, Bijzet J, Bootsma H, Limburg PC, Kallenberg CG. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum 2003;48:248-54.
25. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9.
26. Gilkeson GS, Pippen AM, Pisetsky DS. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995;95:1398-402.
27. Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 1989;142:1482-6.
28. Onishi Y, Kato M, Hanyu Y. Preparation and characterization of an anti-DNA monoclonal antibody showing size selectivity toward DNA fragments. Hybrid Hybridomics 2004;23:311-7.
29. Richardson B, Ray D, Yung R. Murine models of lupus induced by hypomethylated T cells. Methods Mol Med 2004;102:285-94.
30. Wang D, Kandimalla ER, Yu D, Tang JX, Agrawal S. Oral administration of second-generation immunomodulatory oligo-nucleotides induces mucosal Th1 immune responses and adjuvant activity. Vaccine 2005;23:2614-22.
31. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
32. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
33. Takeshita F, Leifer CA, Gursel I et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001;167:3555-8.
34. Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001;98:9237-42.
35. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998;160:5898-906.
36. Lener P, George A, Handwerger BS, Ashman RF. Innate immune response in lupus-prone Palmerston North mice: Differential responses to UPS and bacterial DNA/CpG oligonucleotides. J Clin Immunol 2003;23:202-13.
37. Brummel R, Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005;174:2429-34
38. Ehrenstein MR, Katz DR, Griffiths MH et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 1995;48:705-11.
39. Mason LJ, Ravirajan CT, Latchman DS, Isenberg DA. A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of 'leaky' SCID mice. Clin Exp Immunol 2001;126:137-42.
40. Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol 1996;157:2082-8.
41. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: Cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmunity 1998;11:557-61.
42. Lee HB, Diamond BA, Blaufox MD. In vivo detection of deposition of radiolabeled lupus anti-kidney antibody and its inhibition by soluble antigen. J Nucl Med 2001;42:138-40.
43. Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci USA 1997;94:1955-60.
44. Putterman C, Diamond B. Immunization with a peptide surrogate for dsDNA induces autoantibody production and renal immune-globulin deposition. J Exp Med 1998;188:29-38.
45. Mostoslavsky G, Fischel R, Yachimovich N et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221-7.
46. Deocharan B, Qing X, Lichauco J, Putterman C. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002;168:3072-8.
47. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
48. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125c:373-89.
49. Shoenfeld Y, Mozes E. Pathogenic idiotypes of autoantibodies in autoimmunity: Lessons from new experimental models of SLE. FASEB J 1990;4:2646-51.
50. Shoenfeld Y. Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 1994;8:1296-301.
51. Mendlovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 1988;85:2260-4.
52. Eilat E, Dayan M, Zinger H, Mozes E. The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc Natl Acad Sci USA 2001;98:1148-53.
53. Dang H, Ogawa N, Takei M, Lazaridis K, Talal N. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. J Immunol 1993;151:7260-7.
54. Tincani A, Balestrieri G, Allegri F et al. Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin Exp Rheumatol 1993;11:129-34.
55. Satake F, Watanabe N, Miyasaka N, Kanai Y, Kubota T. Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: Mechanism and characterization. Lupus 2000;9:489-97.
56. Rombach E, Stetler DA, Brown JC. Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody. Clin Exp Immunol 1993;94:466-72.
57. Isenberg DA, Katz D, Le Page S et al. Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor? J Immunol 1991;147:4172-7.
58. Shoenfeld Y. The idiotypic network in autoimmunity: Antibodies that bind antibodies that bind antibodies. Nat Med 2004;10:17-8.
59. Ye YL, Chiang BL. Reconstitution of severe combined immuno-deficient mice with spleen cells from autoimmune NZBxNZW F1 mice. Clin Exp Rheumatol 1998;16:33-7.
60. Sthoeger Z, Zinger H, Dekel B, Arditi F, Reisner Y, Mozes E. Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras. J Clin Immunol 2003;23:91-9.
61. Mauermann N, Sthoeger Z, Zinger H, Mozes E. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 2004;137:513-20.
62. Limpanasithikul W, Ray S, Diamond B. Cross-reactive antibodies have both protective and pathogenic potential. J Immunol 1995;155:967-73.
63. Portis T, Ikeda M, Longnecker R. Epstein-Barr virus LMP2A: Regulating cellular ubiquitination processes for maintenance of viral latency? Trends Immunol 2004;25:422-6.
64. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24:584-8.
65. Kuo P, Bynoe MS, Wang C, Diamond B. Bcl-2 leads to expression of anti-DNA B cells but no nephritis: A model for a clinical subset. Eur J Immunol 1999;29:3168-78.
66. Hoyer BF, Moser K, Hauser AE et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004;199:1577-84.